Prevalence of Regulatory T Cells Is Increased in Peripheral Blood and Tumor Microenvironment of Patients with Pancreas or Breast Adenocarcinoma1
By U. Liyanage, T. Moore, H. Joo, Yoshiyuki Tanaka, V. Herrmann, G. Doherty, J. Drebin, S. Strasberg, T. Eberlein, P. Goedegebuure and 1 more. Journal of Immunology, 2002
1,554 citations recorded by the source corpus.
Subfields: Immunology, Oncology
View Paper: https://www.semanticscholar.org/paper/8c3ce50ae099f3ed7d381a648b7b5e7b246e5bef
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Immunology
- D. Pardoll
- A. Puisieux
- Charles G. Drake
- Marc Beyer
- Joachim L. Schultze
- Jacques Banchereau
- Antoni Ribas
- K. Palucka
In Oncology
- D. Pardoll
- Charles G. Drake
- A. Puisieux
- Joachim L. Schultze
- Antoni Ribas
- Jacques Banchereau
- K. Palucka
- J. Wolchok
Citations in the corpus
- The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors. (2006, background): “A possible interaction between T lymphocytes expressing B7-H1 and T-reg may exist, as has been shown recently by Krupnick et al. [44].”
- Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. (2005, background): “Recently, several studies have reported an increase in number of regulatory T cells in patients with different cancers (20, 23, 43, 44).”